Our study showed that in Zucker diabetic fatty (ZDF) rats which are characterized by homozygous mutation in Lepr gene, Lepr defective can offset metformin’s therapeutic effect on liver steatosis and weight gain, and instead lead to liver function damage. This evidence concerns the gene LEPR and Hepatic steatosis.